Alex D'souzaManaging Editoreditor@healthcaretechoutlook.comWith healthcare shifting from reactive to preventive medicine, genetic diagnostics is playing a crucial role in predicting the progression of diseases based on the information in the DNA. From using gene probes to locate segments of normal or mutated DNA to leveraging microchips to identify DNA mutations, the genetic diagnostics domain is pushing the bounds of possibilities in medicine. These trends have pivoted the genetic testing market beyond $14.8 billion in 2020, and will propel it further at a CAGR of 11.6 percent by 2027.The growth is especially driven by the role of genetic testing in delivering early care for patients, especially in the case of cancer, where timely intervention is the difference between life and death. Among the most exciting innovations in the genetic diagnostics segment are the next-generation sequencing technologies, which are allowing care practitioners to determine if a gene contains variants or mutations that are causing the disorder. Combined with other emerging technologies in the genetic diagnostics market, DNA sequencing is indeed dawning a new era in the treatment of life-threatening diseases.To put the spotlight on such key developments in the industry, Healthcare Tech Outlook features thought leadership articles from Derya DLEK KANÇAI, Ph.D., laboratory manager of Acibadem Labcell Cellular Therapy, Patrick Young, president of population health at Hackensack Meridian Health, and Alexander Koster, director of VBSO analytics and technology at Nemours, who shed light on the future of immunotherapy, utilization of technology to advance population health strategies, and the recovery and re-imagination of healthcare in the post-COVID era.In this edition of Healthcare Tech Outlook magazine, we also bring to you the story of some of the top genetic diagnostics solutions providers that deliver the best outcomes for healthcare providers as well as the patients. In the list, Synergy Laboratories, particularly, stands out for its Molecular PCR and Next-Gen Sequencing services that can quickly segment and amplify DNA to detect bacteria, viruses, and mutations. Another notable mention is Premier Medical, an industry leader in molecular diagnostics, which leverages latest technologies like liquid chromatography mass spectromery (LCMS), molecular, and allergy testing equipment to provide the most accurate interpretations at unsurpassed turnaround times.Through the following pages, we aim to shine a light on the innovative trends and latest developments in the genetic diagnostics space. We would like to know your thoughts.Pushing the Limits of Preventive Medicine with DNA Sequencing EditorialManaging EditorAlex D'souzaEditorial StaffAaron PaulJoe PhillipJames SmithMark Robert Wilson BrunoVega StanleyDavis MillsDebbie WillisVisualizerUTLOOKHealthcare Tech Copyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEmail:sales@healthcaretechoutlook.comeditor@healthcaretechoutlook.commarketing@healthcaretechoutlook.comImmanuelChris LynnSalesRich Gonsalves rich@healthcaretechoutlook.comSeptember - 12 - 2022, volume 08 - Issue 08 Published by ValleyMedia, Inc. (ISSN 2691 - 3933)To subscribe to HealthcareTech OutlookVisit www.healthcaretechoutlook.com UTLOOKHealthcare Tech
< Page 5 | Page 7 >